These findings warrant further investigation of cyclophilin inhibition, including whether prophylactic cyclophilin inhibition can prevent acute kidney injury in anticipated renal IRI as occurs in patients undergoing coronary artery bypass graft surgery or kidney transplantation. This evidence concerns the gene PPIB and acute kidney injury.